ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!PEPG Company Profile and Key Details
PepGen Inc.
PEPG Stock Price Chart
Stock Price Today
PepGen Inc. (PEPG) stock surged +15.64%, trading at $2.81 on NASDAQ, up from the previous close of $2.43. The stock opened at $2.43, fluctuating between $2.26 and $3.00 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
Company Information
| Employees | 76 |
| Beta | 1.52 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
PepGen Inc. (NASDAQ: PEPG) stock price is $2.81 in the last trading session. During the trading session, PEPG stock reached the peak price of $3.00 while $2.26 was the lowest point it dropped to. The percentage change in PEPG stock occurred in the recent session was 15.64% while the dollar amount for the price change in PEPG stock was $0.38.
The NASDAQ listed PEPG is part of Biotechnology industry that operates in the broader Healthcare sector. PepGen Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Jennifer Cormier
Senior Vice President of Clinical Operations
Dr. James G. McArthur Ph.D.
Pres, Chief Executive Officer, Treasurer, Sec. & Director
Dr. Jaya Goyal Ph.D.
Executive Vice President of Research & Preclinical Devel.
Mr. Niels Svenstrup Ph.D.
Senior Vice President of Chemistry, Manufacturing & Control
Ms. Caroline Godfrey Ph.D.
Founder & Scientific Advisory Board Member
Dr. Michael Gait
Founder & Scientific Advisory Board Member
Mr. Kyle Breidenstine
Vice President of Fin. & Controller
Mr. Noel Donnelly M.B.A.
Chief Financial Officer
Dr. Sonia Bracegirdle DPHIL
Senior Vice President of Strategy & Operations
Dr. Michelle L. Mellion M.D.
Senior Vice President & Head of Clinical Devel.
Mr. Noel P. Donnelly M.B.A.
Chief Financial Officer
PEPG's closing price is 109.48% higher than its 52-week low of $1.16 where as its distance from 52-week high of $19.30 is -87.41%.
Number of PEPG employees currently stands at 76.
Official Website of PEPG is: https://www.pepgen.com
PEPG could be contacted at phone 781 797 0979 and can also be accessed through its website. PEPG operates from 245 Main Street, Cambridge, MA 02142, United States.
PEPG stock volume for the day was 6.46M shares. The average number of PEPG shares traded daily for last 3 months was 2.65M.
The market value of PEPG currently stands at $91.87M with its latest stock price at $2.81 and 32.69M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com